Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation

Clinical Cancer Research

Volumn 13, Issue 17, 2007, Pages 5176-5182

  Martin, Robert C G ^a   Liu, Qiaohong ^a   Wo, John M ^a   Ray, Mukunda B ^a   Li, Yan ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; GLUTATHIONE; MANGANESE SUPEROXIDE DISMUTASE; MANGANESE TETRAKIS(4 BENZOIC ACID) PORPHYRIN; PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG; 8 HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2'-DEOXYGUANOSINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; DEOXYGUANOSINE; DRUG DERIVATIVE; MANGANESE(III) TETRAKIS(4 BENZOIC ACID)PORPHYRIN; MANGANESE(III)-TETRAKIS(4-BENZOIC ACID)PORPHYRIN; METALLOPORPHYRIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME ACTIVITY; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REFLUX ESOPHAGITIS; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; APOPTOSIS; CELL PROLIFERATION; ESOPHAGUS; ESOPHAGUS TUMOR; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADENOCARCINOMA; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CELL PROLIFERATION; DEOXYGUANOSINE; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; METALLOPORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 34548827609     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1152     Document Type: Article

References (38)

1. Pera M, Manterola C, Vidal O, et al. Epidemiology of esophageal adenocarcinoma. J Surg Oncol 2005;92:151-9.
2. Farrow DC, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control 1996;7:322-7.
3. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
4. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-52.
5. Tew WP, Kelsen DP, Ilson DH. Targeted therapies for esophageal cancer. Oncologist 2005;10:590-601.
6. Wetscher GJ, Hinder RA, Klingler P, et al. Reflux esophagitis in humans is a free radical event. Dis Esophagus 1997;10:29-32.
7. Olyaee M, Sontag S, Salman W, et al. Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut 1995;37:168-73.
8. Davies KJA. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 2000;50:279-89.
9. Chen XX, Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 2001;22:1119-29.
10. Li Y, Wo JM, Su RR, et al. Esophageal injury with external esophageal perfusion. J Surg Res 2005;129:107-13.
11. Li Y, Wo JM, Ellis S, et al. Morphological transformation in esophageal submucosa by bone marrow cells: esophageal implantation under external esophageal perfusion. Stem Cells Dev 2006;15:697-705.
12. Li Y, Wo JM, Ellis S, et al. A novel external esophageal perfusion model for reflux esophageal injury. Dig Dis Sci 2006;51:527-32.
13. Li Y, Wo JM, Su RR, et al. Loss of manganese superoxide dismutase expression and activity in rat esophagus with external esophageal perfusion. Surgery 2007;141:359-67.
14. Piazuelo E, Cebrian C, Escartin A, et al. Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus. World J Gastroenterol 2005;11:7436-43.
15. Wispe JR, Warner BB, Clark JC, et al. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 1992;267:23937-41.
16. Simonson SG, Welty-Wolf KE, Huang YC, et al. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. I. Physiology and biochemistry. J Appl Physiol 1997;83:550-8.
17. Patel M, Day BJ. Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol Sci 1999;20:359-64.
18. Day BJ, Fridovich I, Crapo JD. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch Biochem Biophys 1997;347:256-62.
19. Patel M, Day BJ, Crapo JD, et al. Requirement for superoxide in excitotoxic cell death. Neuron 1996;16:345-55.
20. Estevez AG, Spear N, Manuel SM, et al. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci 1998;18:923-31.
21. Cuzzocrea S, Zingarelli B, Costantino G, et al. Beneficial effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in carrageenan-induced pleurisy. Free Radic Biol Med 1999;26:25-33.
22. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163-74.
23. Chen XX, Ding YW, Yang GY, et al. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 2000;21:257-63.
24. Buttar NS, Wang KK, Leontovich O, et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002;122:1101-12.
25. Goldstein SR, Yang GY, Curtis SK, et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997;18:2265-70.
26. Li Y, Wo JM, Su RR, et al. Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Ann Surg Oncol 2007;14:2045-55.
27. Lanas A, Soteras F, Jimenez P, et al. Superoxide anion and nitric oxide in high-grade esophagitis induced by acid and pepsin in rabbits. Dig Dis Sci 2001;46:2733-43.
28. Naya MJ, Pereboom D, Ortego J, et al. Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oesophagitis in rabbits. Gut 1997;40:175-81.
29. Wetscher GJ, Perdikis G, Kretchmar DH, et al. Esophagitis in Sprague-Dawley rats is mediated by free-radicals. Dig Dis Sci 1995;40:1297-305.
30. Jankowski JA, Wright NA, Meltzer SJ, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999;154:965-73.
31. Prach AT, MacDonald TA, Hopwood DA, et al. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet 1997;350:933.
32. Li Y, Huang TT, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995;11:376-81.
33. Weiss RH, Flickinger AG, Rivers WJ, et al. Evaluation of activity of putative superoxide dismutase mimics. Direct analysis by stopped-flow kinetics. J Biol Chem 1993;268:23049-54.
34. Ferret PJ, Hammoud R, Tulliez M, et al. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 2001;33:1173-80.
35. Malassagne B, Ferret PJ, Hammoud R, et al. The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in themouse. Gastroenterology 2001;121:1451-9.
36. Janssen AM, Bosman CB, Sier CF, et al. Superoxide dismutases in relation to the overall survival of colorectal cancer patients. Br J Cancer 1998;78:1051-7.
37. Epperly MW, Kagan VE, Sikora CA, et al. Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation. Int J Cancer 2001;96:221-31.
38. Stickle RL, Epperly MW, Klein E, et al. Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene. Radiat Oncol Investig 1999;7:204-17.